Clinical Trials
2 trialsNCT05053971 2026-04-13
Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1/2 Recruiting
NCT03838042 2024-02-07
INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies
University Hospital Heidelberg
Phase 1/2 Recruiting